Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol in Age-related Insulin Resistance and Inflammation
NCT01354977Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Mar 2008
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of resveratrol in type 2 diabetes mellitus (T2DM), insulin resistance (IR), sponsored by Albert Einstein College of Medicine. Started Mar 2008; status: completed.
02
Drugs
resveratrol
03
Conditions
type 2 diabetes mellitus (T2DM)insulin resistance (IR)
Beyond the preview
Go deeper on NCT01354977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01354977.